Incepta Vaccine Ltd.
↗Dhaka, Bangladesh
Incepta Vaccine Ltd. is the first human vaccine manufacturing company in Bangladesh, established in 2009/2011. The company operates a state-of-the-art, WHO-GMP compliant manufacturing facility in Zirabo, Savar, with a large capacity for producing various types of vaccines, including viral, bacterial, and recombinant protein-based vaccines, to serve both local and global markets.
The company is a subsidiary of Incepta Pharmaceuticals Ltd., one of the largest pharmaceutical companies in Bangladesh. Incepta Vaccine focuses on R&D for novel vaccines and has engaged in international collaborations, including technology transfers for COVID-19 vaccine development and partnerships with organizations like the International Vaccine Institute (IVI) and the Bill & Melinda Gates Foundation.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Founded:2009
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Inactivated vaccine, Subunit vaccine, Recombinant vaccine, Polysaccharide vaccine, Conjugate vaccine
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Incepta Pharmaceuticals Ltd.
Key Partnerships:International Vaccine Institute (IVI), Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Bill & Melinda Gates Foundation, Murdoch Children's Research Institute
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Abdul Muktadir - Chairman
LINKS
Website:inceptavaccine.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Incepta Vaccine Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Incepta Vaccine Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.